- Home
- CPB vs PEN Comparison
CPB vs PEN Comparison
Compare CPB & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPB
- PEN
- Stock Information
- Founded
- CPB 1869
- PEN 2004
- Country
- CPB United States
- PEN United States
- Employees
- CPB N/A
- PEN N/A
- Industry
- CPB Packaged Foods
- PEN Medical/Dental Instruments
- Sector
- CPB Consumer Staples
- PEN Health Care
- Exchange
- CPB Nasdaq
- PEN Nasdaq
- Market Cap
- CPB 10.5B
- PEN 10.6B
- IPO Year
- CPB N/A
- PEN 2015
- Fundamental
- Price
- CPB $31.84
- PEN $256.69
- Analyst Decision
- CPB Hold
- PEN Strong Buy
- Analyst Count
- CPB 17
- PEN 16
- Target Price
- CPB $40.06
- PEN $299.73
- AVG Volume (30 Days)
- CPB 5.1M
- PEN 433.2K
- Earning Date
- CPB 06-02-2025
- PEN 07-29-2025
- Dividend Yield
- CPB 4.92%
- PEN N/A
- EPS Growth
- CPB N/A
- PEN N/A
- EPS
- CPB 1.50
- PEN 1.08
- Revenue
- CPB $10,225,000,000.00
- PEN $1,240,100,000.00
- Revenue This Year
- CPB $7.91
- PEN $14.60
- Revenue Next Year
- CPB N/A
- PEN $14.24
- P/E Ratio
- CPB $21.11
- PEN $239.29
- Revenue Growth
- CPB 8.65
- PEN 13.17
- 52 Week Low
- CPB $31.58
- PEN $148.00
- 52 Week High
- CPB $52.81
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- CPB 26.91
- PEN 40.56
- Support Level
- CPB $31.58
- PEN $249.09
- Resistance Level
- CPB $33.58
- PEN $265.48
- Average True Range (ATR)
- CPB 0.71
- PEN 6.58
- MACD
- CPB -0.15
- PEN 0.62
- Stochastic Oscillator
- CPB 7.60
- PEN 40.53
About CPB Campbell Soup Company
Over the past 150-plus years, Campbell has evolved into a leading packaged food manufacturer in North America, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2024, snacks accounted for nearly half of its revenue, followed by soup (28%), other simple meals (17%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in March 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.